Literature DB >> 20051663

Clinical presentation and outcome of geriatric depression in subcortical ischemic vascular disease.

R Bella1, G Pennisi, M Cantone, F Palermo, M Pennisi, G Lanza, M Zappia, S Paolucci.   

Abstract

BACKGROUND: Vascular damage of frontal-subcortical circuits involved in mood regulation and cognition might be the main contributor to the pathogenesis of late-life depression, and it is linked to poor response to treatment.
OBJECTIVE: To investigate the relationship between executive dysfunction and outcome of depressive symptoms among elderly patients with subcortical ischemic vascular disease.
METHODS: Ninety-two elderly patients with white matter lesions (WMLs) or lacunar infarcts (LAs) on brain MRI and depressive symptomatology were consecutively recruited. Depression was rated with the Hamilton Depression Rating Scale (HDRS). Evaluation of executive functions by means of the Stroop color-word test was performed at entry of the study, and WMLs were categorized into mild, moderate or severe. Mood was reevaluated by means of HDRS after the 12th week of pharmacological treatment.
RESULTS: Psychomotor retardation, difficulties at work, apathy, and lack of insight were the predominant symptoms. Fifty-six patients (62.8%) had a neuroradiological picture of WMLs, while the remaining 33 (37.1%) had LAs. Executive dysfunctions significantly and independently predict poor outcome of depressive symptoms. Patients with the severest WMLs showed not only a greater executive dysfunction, but also a minor response to antidepressant treatment.
CONCLUSION: This study supports the vascular depression hypothesis. WMLs are of crucial clinical relevance as they are linked with cognitive symptoms and poor antidepressant outcome. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20051663     DOI: 10.1159/000272003

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  32 in total

1.  Magnetic resonance imaging predictors of treatment response in late-life depression.

Authors:  Howard J Aizenstein; Alexander Khalaf; Sarah E Walker; Carmen Andreescu
Journal:  J Geriatr Psychiatry Neurol       Date:  2013-12-30       Impact factor: 2.680

Review 2.  Developments in treating the nonmotor symptoms of stroke.

Authors:  Argye E Hillis
Journal:  Expert Rev Neurother       Date:  2020-05-12       Impact factor: 4.618

Review 3.  The vascular depression hypothesis: mechanisms linking vascular disease with depression.

Authors:  W D Taylor; H J Aizenstein; G S Alexopoulos
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

4.  Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test.

Authors:  N A Addy; E J Nunes; R J Wickham
Journal:  Behav Brain Res       Date:  2015-04-09       Impact factor: 3.332

5.  The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.

Authors:  Samantha E Yohn; Christian Thompson; Patrick A Randall; Christie A Lee; Christa E Müller; Younis Baqi; Mercè Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2014-10-17       Impact factor: 4.530

6.  Impaired cerebral hemodynamics in late-onset depression: computed tomography angiography, computed tomography perfusion, and magnetic resonance imaging evaluation.

Authors:  Jinhong Wang; Renren Li; Meng Liu; Zhiyu Nie; Lingjing Jin; Zheng Lu; Yunxia Li
Journal:  Quant Imaging Med Surg       Date:  2020-09

Review 7.  Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.

Authors:  Marnix J M van Agtmaal; Alfons J H M Houben; Frans Pouwer; Coen D A Stehouwer; Miranda T Schram
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

Review 8.  Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.

Authors:  Lilia Zurkovsky; Warren D Taylor; Paul A Newhouse
Journal:  Biochem Pharmacol       Date:  2013-08-08       Impact factor: 5.858

9.  Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.

Authors:  Eric J Nunes; Patrick A Randall; Evan E Hart; Charlotte Freeland; Samantha E Yohn; Younis Baqi; Christa E Müller; Laura López-Cruz; Mercè Correa; John D Salamone
Journal:  J Neurosci       Date:  2013-12-04       Impact factor: 6.167

10.  The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression.

Authors:  Sanne J H van Rooij; Patricio Riva-Posse; William M McDonald
Journal:  Curr Treat Options Psychiatry       Date:  2020-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.